Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial

Clinical trial NCT02373124 · COMPLETED

Trial details

NCT number: NCT02373124
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cocaine Use Disorders

Start date: 2014-12-01
Primary completion: 2016-10-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.